\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ focal\\ neurological\\ deficit\ \(6\)\
\-\ surgery\\ and\\ radiation\\ therapy\ \(3\)\
\-\ \\â\\€\\¢\\ ct\\-\\-heterogeneous\\ left\\ hemisphere\\ mass\\ with\\ curvilinear\\ marginal\\ calcifications\\.\ \(0\)\
\-\ \\â\\€\\¢\\ mri\\-\\-infiltrative\\,\\ poorly\\ marginated\\ mass\\ with\\ evidence\\ of\\ leptomeningeal\\ spread\\.\\ \\ significant\\ mass\\ effect\\ and\\ irregular\\ enhancement\\ following\\ contrast\\ administration\\.\\ the\\ tumor\\ extends\\ from\\ the\\ middle\\ cranial\\ fossa\\,\\ over\\ the\\ tentorium\\,\\ and\\ into\\ the\\ posterior\\ cranial\\ fossa\\.\ \(0\)\
\-\ anaplastic\\ oligodendroglioma\\ \\(who\\ gr\\ 3\\)\ \(0\)\
\-\ \\â\\€\\¢\\ astrocytoma\\ \\(who\\ 3\\,4\\ \\-\\ gbm\\)\ \(0\)\
\-\ \\â\\€\\¢\\ oligodendroglioma\\,\\ oligoastrocytoma\\ \\(possibly\\ anaplastic\\)\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ 44\\ year\\ old\\ man\\ presents\\ to\\ outside\\ hospital\\ with\\ headache\\ and\\ confusion\\.\\ \\ his\\ family\\ states\\ has\\ \\"not\\ been\\ himself\\"\\ for\\ the\\ past\\ month\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ anaplastic\\:\\ 0\\.09044590284842607\ \(0\)\
\-\ oligodendroglioma\\:\\ 0\\.08418245267556602\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.07900912697122124\ \(0\)\
\-\ \\-\\-\\:\\ 0\\.06596923186125621\ \(0\)\
\-\ cranial\\:\\ 0\\.06244793270827394\ \(0\)\
\-\ oligoastrocytoma\\:\\ 0\\.062430454309635355\ \(0\)\
\-\ fossa\\:\\ 0\\.05853444757480889\ \(0\)\
\-\ 3\\,4\\:\\ 0\\.05561591467756536\ \(0\)\
\-\ himself\\:\\ 0\\.05252579047483161\ \(0\)\
\-\ gr\\:\\ 0\\.05078092186324972\ \(0\)\
\-\ tentorium\\:\\ 0\\.04810484008914439\ \(0\)\
\-\ marginal\\:\\ 0\\.04703061007645628\ \(0\)\
\-\ marginated\\:\\ 0\\.04396638223117973\ \(0\)\
\-\ confusion\\:\\ 0\\.04308099974666018\ \(0\)\
\-\ leptomeningeal\\:\\ 0\\.04267099836708512\ \(0\)\
\-\ gbm\\:\\ 0\\.04247326309473055\ \(0\)\
\-\ curvilinear\\:\\ 0\\.041375614502990515\ \(0\)\
\-\ infiltrative\\:\\ 0\\.04120584385326346\ \(0\)\
\-\ who\\:\\ 0\\.037444847212465576\ \(0\)\
\-\ deficit\\:\\ 0\\.03704873257732979\ \(0\)\
\-\ 44\\:\\ 0\\.0368462321438923\ \(0\)\
\-\ possibly\\:\\ 0\\.03674678291996791\ \(0\)\
\-\ hemisphere\\:\\ 0\\.036551347103461466\ \(0\)\
\-\ poorly\\:\\ 0\\.03505149180525316\ \(0\)\
\-\ spread\\:\\ 0\\.03473434619195192\ \(0\)\
\-\ states\\:\\ 0\\.033779225868653416\ \(0\)\
\-\ extends\\:\\ 0\\.03112210618159626\ \(0\)\
\-\ neurological\\:\\ 0\\.031071635391174312\ \(0\)\
\-\ outside\\:\\ 0\\.03012109081606648\ \(0\)\
\-\ mass\\:\\ 0\\.029961201855820956\ \(0\)\
\-\ administration\\:\\ 0\\.029812271133640083\ \(0\)\
\-\ family\\:\\ 0\\.029431197016174037\ \(0\)\
\-\ irregular\\:\\ 0\\.02864156850845697\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.027885295787170555\ \(0\)\
\-\ hospital\\:\\ 0\\.02703442407536238\ \(0\)\
\-\ calcifications\\:\\ 0\\.0266988550809475\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.026405001317605085\ \(0\)\
\-\ middle\\:\\ 0\\.026261840081028887\ \(0\)\
\-\ effect\\:\\ 0\\.025424859269489453\ \(0\)\
\-\ headache\\:\\ 0\\.02466374317282183\ \(0\)\
\-\ radiation\\:\\ 0\\.023565136550944003\ \(0\)\
\-\ past\\:\\ 0\\.02281680228526415\ \(0\)\
\-\ month\\:\\ 0\\.021542979334458902\ \(0\)\
\-\ his\\:\\ 0\\.020696546450814552\ \(0\)\
\-\ lymphoma\\:\\ 0\\.020522677599911644\ \(0\)\
\-\ focal\\:\\ 0\\.02050834961460842\ \(0\)\
\-\ following\\:\\ 0\\.02038048535211049\ \(0\)\
\-\ been\\:\\ 0\\.019536091508100765\ \(0\)\
\-\ significant\\:\\ 0\\.019309639924825404\ \(0\)\
\-\ enhancement\\:\\ 0\\.019247804757336437\ \(0\)\
\-\ therapy\\:\\ 0\\.01919866215328246\ \(0\)\
\-\ evidence\\:\\ 0\\.018827248599721663\ \(0\)\
\-\ over\\:\\ 0\\.01828271084151229\ \(0\)\
\-\ \\(\\:\\ 0\\.018210799821273795\ \(0\)\
\-\ metastatic\\:\\ 0\\.018076549610219244\ \(0\)\
\-\ \\)\\:\\ 0\\.017988345179327018\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.01764819359354468\ \(0\)\
\-\ surgery\\:\\ 0\\.01743696692739727\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.017308819344388594\ \(0\)\
\-\ into\\:\\ 0\\.017086776201342073\ \(0\)\
\-\ man\\:\\ 0\\.01698262053016806\ \(0\)\
\-\ 3\\:\\ 0\\.01681492039249193\ \(0\)\
\-\ tumor\\:\\ 0\\.01674144791269589\ \(0\)\
\-\ posterior\\:\\ 0\\.01655158444287772\ \(0\)\
\-\ mri\\:\\ 0\\.016498116427853947\ \(0\)\
\-\ contrast\\:\\ 0\\.01607374526729332\ \(0\)\
\-\ \\-\\:\\ 0\\.015392676123599692\ \(0\)\
\-\ presents\\:\\ 0\\.01466927979418425\ \(0\)\
\-\ has\\:\\ 0\\.013484873701632587\ \(0\)\
\-\ disease\\:\\ 0\\.011737290262316841\ \(0\)\
\-\ from\\:\\ 0\\.010642316917262288\ \(0\)\
\-\ not\\:\\ 0\\.01037662749362971\ \(0\)\
\-\ ct\\:\\ 0\\.01004456851589952\ \(0\)\
\-\ \\,\\:\\ 0\\.009099498000581088\ \(0\)\
\-\ left\\:\\ 0\\.00803449806111693\ \(0\)\
\-\ year\\:\\ 0\\.00803449806111693\ \(0\)\
\-\ old\\:\\ 0\\.007352391570271047\ \(0\)\
\-\ no\\:\\ 0\\.007230623115158\ \(0\)\
\-\ for\\:\\ 0\\.006126959232291724\ \(0\)\
\-\ and\\:\\ 0\\.0060507228817552414\ \(0\)\
\-\ the\\:\\ 0\\.0058087934749422605\ \(0\)\
\-\ to\\:\\ 0\\.0035888076339746743\ \(0\)\
\-\ with\\:\\ 0\\.0029496851115098253\ \(0\)\
\-\ \\.\\:\\ 0\\.001789892576336787\ \(0\)\
\-\ of\\:\\ 0\\.0009790235361175497\ \(0\)\
